Skip to main content
ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
6.41
-0.19 (-2.88%)
Mar 9, 2026, 1:58 PM EDT - Market open

ImmuCell Revenue

In the year 2025, ImmuCell had annual revenue of $27.64M with 4.34% growth. ImmuCell had revenue of $7.63M in the quarter ending December 31, 2025, a decrease of -1.61%.

Revenue (ttm)
$27.64M
Revenue Growth
+4.34%
P/S Ratio
2.16
Revenue / Employee
$329,095
Employees
84
Market Cap
57.98M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202527.64M1.15M4.34%
Dec 31, 202426.49M9.02M51.64%
Dec 31, 202317.47M-1.10M-5.90%
Dec 31, 202218.57M-675.01K-3.51%
Dec 31, 202119.24M3.90M25.43%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
TScan Therapeutics 10.33M
NeurAxis 3.36M
BeyondSpring 1.88M
ImageneBio 800.00K
Spruce Biosciences 697.00K
Rallybio 674.00K
Mereo BioPharma Group 500.00K
Entera Bio 124.00K
Revenue Rankings

ICCC News

More News